Boston Scientific (BSX) Tops Q2 EPS by 4 cents; raises EPS guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $46.32 +6.48%
Financial Fact:
Intangible asset impairment charges: 7M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Intangible asset impairment charges: 7M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.53, $0.04 better than the analyst estimate of $0.49. Revenue for the quarter came in at $3.6 billion versus the consensus estimate of $3.5 billion.
GUIDANCE:
Boston Scientific sees Q3 2023 EPS of $0.46-$0.48, versus the consensus of $0.48.
Boston Scientific sees FY2023 EPS of $1.96-$2.00, versus the consensus of $1.95.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance
- Grainger (GWW) Tops Q3 EPS by 87c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
